Evidence map›Paper›PMID 27905421›Full record

ArticleNature2016

Consistency in drug response profiling.

John Patrick Mpindi, Bhagwan Yadav, Päivi Östling, Prson Gautam, Disha Malani, Astrid Murumägi, Akira Hirasawa, Sara Kangaspeska, Krister Wennerberg, Olli Kallioniemi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Harmonization and integration of pharmacogenomics screens.Bioinformatics (Oxford, England) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells.Journal of experimental & clinical cancer research : CR · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

John Patrick MpindiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00290 Helsinki, Finland.
Bhagwan YadavInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00290 Helsinki, Finland.
Päivi ÖstlingInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00290 Helsinki, Finland.
Prson GautamInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00290 Helsinki, Finland.
Disha MalaniInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00290 Helsinki, Finland.
Astrid MurumägiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00290 Helsinki, Finland.
Akira HirasawaInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00290 Helsinki, Finland.
Sara KangaspeskaInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00290 Helsinki, Finland.
Krister WennerbergInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00290 Helsinki, Finland.
Olli KallioniemiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00290 Helsinki, Finland.
Tero AittokallioInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, 00290 Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27905421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.